FMC Corporation 2001 Annual Report (10-K) Summary
Business Context and Reporting Period
Reporting Period: Fiscal year ended December 31, 2001.
Business Overview: FMC Corporation is a diversified chemical company operating in three segments: Agricultural Products, Specialty Chemicals, and Industrial Chemicals. The company serves global markets with crop protection, food/pharmaceutical ingredients, and industrial inorganic materials.
Major Corporate Event: Effective December 31, 2001, FMC completed a strategic separation into two independent public companies. FMC retained its chemical businesses, while the former Energy Systems and Food and Transportation Systems segments were spun off as FMC Technologies, Inc. ("Technologies"). Historical financial data has been reclassified to reflect Technologies as discontinued operations.
Key Financial Metrics (2001)
| Metric | 2001 (in millions) | 2000 (in millions) |
|---|---|---|
| Revenue | $1,943.0 | $2,050.3 |
| Net Income (Loss) | $(337.7) | $110.6 |
| Income from Continuing Ops (Loss) | $(306.3) | $125.6 |
| Adjusted Income (Excl. Special Items) | $99.6 | $153.5 |
| Operating Cash Flow | $(90.0) | $298.3 |
| Capital Expenditures | $145.6 | $197.3 |
| Total Debt (Short + Long Term) | $923.5 | $1,007.5 |
| Cash and Equivalents | $23.4 | $7.3 |
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased 5.2% to $1,943.0 million, driven by weaker demand in Industrial Chemicals and the loss of significant sulfentrazone sales to DuPont in Agricultural Products.
- Net Loss: The company reported a net loss of $337.7 million, a reversal from the $110.6 million profit in 2000. This was primarily due to $603.5 million in pre-tax special items, including asset impairments and restructuring charges.
- Asset Impairments: Total impairments were $323.1 million, largely driven by:
- $211.9 million related to the U.S. phosphorus business (Pocatello, Idaho facility and Astaris joint venture).
- $98.9 million related to lithium operations in Argentina.
- Restructuring Charges: Charges totaled $280.4 million, focused on the shutdown of the Pocatello phosphorus plant, corporate reorganization, and workforce reductions (approx. 317 employees in 2001).
- Segment Performance:
- Agricultural Products: Operating profit declined 17.1% due to lost DuPont volumes and weaker Asian markets.
- Specialty Chemicals: Operating profit declined slightly; lithium revenues fell due to strategic exits from commodity markets.
- Industrial Chemicals: Operating profit dropped 36.6% due to lower soda ash/hydrogen peroxide volumes and reduced earnings from the Astaris joint venture.
Guidance, Outlook, and Risks
Management Outlook:
- Management expects the Industrial Chemicals segment to improve in 2002 following the restructuring of the U.S. phosphorus business and the full operation of the new Astaris PPA plant.
- Agricultural Products faces a challenging 2002 but anticipates recovery through label expansions and cost reductions.
- Capital expenditures are expected to decrease in 2002 due to the absence of significant Consent Decree spending at Pocatello.
- No cash dividends are expected to be paid in 2002.
Key Risks and Contingencies:
- Environmental Obligations: Total reserves are $260.4 million. Significant uncertainty remains regarding the Pocatello site remediation and potential future costs.
- Debt and Liquidity: The company carries significant indebtedness ($923.5 million). A downgrade in credit ratings could restrict access to capital markets. The company relies on a $240 million revolving credit facility and commercial paper.
- Joint Venture Guarantees: FMC has agreed to make equity contributions to the Astaris joint venture to cover earnings shortfalls; a $31.3 million contribution was made in 2001, with a similar amount expected in 2002.
- Foreign Exchange: The company is sensitive to fluctuations in the Euro and Brazilian Real, which adversely impacted 2001 results.
Investor Verification Checklist
- Spin-off Accounting: Verify the reclassification of Technologies' assets and liabilities to discontinued operations and the impact on comparative financial statements.
- Asset Impairment Details: Review Note 6 for the specific valuation assumptions used for the $323.1 million impairment, particularly regarding the Pocatello facility and Argentina lithium assets.
- Environmental Reserves: Assess the adequacy of the $260.4 million environmental reserve against the potential for increased costs at the Pocatello site and other discontinued operations.
- Astaris Joint Venture: Monitor the performance of the Astaris joint venture and FMC's ongoing obligation to fund earnings shortfalls.
- Debt Covenants: Confirm continued compliance with leverage and interest coverage covenants under the new $240 million credit facility.
- Adjusted Earnings: Scrutinize the "Adjusted Income" metric ($99.6 million) to understand the underlying operational performance excluding one-time restructuring and impairment charges.